1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. CorMedix Inc.
  6. News
  7. Summary
    CRMD   US21900C3088

CORMEDIX INC.

(CRMD)
  Report
Delayed Nasdaq  -  04:00 2022-08-05 pm EDT
7.130 USD   +8.85%
08/01CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11
AQ
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 2500 Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 2000 Dynamic Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CorMedix: Q1 Earnings Snapshot

05/12/2022 | 04:26pm EDT

BERKELEY HEIGHTS, N.J. (AP) _ CorMedix Inc. (CRMD) on Thursday reported a loss of $7 million in its first quarter.

The Berkeley Heights, New Jersey-based company said it had a loss of 18 cents per share.

The pharmaceutical and medical device company posted revenue of $7,600 in the period. Its adjusted revenue was $8,000.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRMD at https://www.zacks.com/ap/CRMD

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about CORMEDIX INC.
08/01CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate U..
AQ
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 2500 Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 2000 Dynamic Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 3000 Growth Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 2000 Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 2000 Growth Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 2000 Value Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell Small Cap Comp Growth Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 3000 Value Index
CI
06/24CORMEDIX INC.(NASDAQGM : CRMD) dropped from Russell 3000E Index
CI
More news
Analyst Recommendations on CORMEDIX INC.
More recommendations
Financials (USD)
Sales 2022 0,64 M - -
Net income 2022 -36,5 M - -
Net cash 2022 118 M - -
P/E ratio 2022 -8,20x
Yield 2022 -
Capitalization 279 M 279 M -
EV / Sales 2022 253x
EV / Sales 2023 8,14x
Nbr of Employees 30
Free-Float 98,7%
Chart CORMEDIX INC.
Duration : Period :
CorMedix Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CORMEDIX INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 7,13 $
Average target price 22,00 $
Spread / Average Target 209%
EPS Revisions
Managers and Directors
Joseph Todisco Chief Executive Officer & Director
Mathew T. David Chief Financial Officer & Executive Vice President
Myron Lawrence Kaplan Chairman
Antony E. Pfaffle Secretary & Chief Scientific Officer
Elizabeth Masson-Hurlburt Executive VP-Clinical & Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
CORMEDIX INC.56.70%279
MERCK KGAA-18.70%81 493
KYOWA KIRIN CO. LTD.-0.32%12 405
SK BIOPHARMACEUTICALS CO., LTD.-16.67%4 866
BETTA PHARMACEUTICALS CO., LTD.-33.13%3 279
YUHAN CORPORATION-6.12%3 047